Barry D. Quart - Chief Executive Officer, Director at HERON THERAPEUTICS, INC. /DE/

Issuer-level insider activity

Role
Chief Executive Officer, Director
Issuer ticker
HRTX on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Barry D. Quart since 18 Aug 2025

Reported holdings for Barry D. Quart in HERON THERAPEUTICS, INC. /DE/

Form 4 holding Chief Executive Officer, Director

HERON THERAPEUTICS, INC. /DE/

Security class
Employee Stock Option (Right to Buy)
Shares / value
850,000
Estimated value
$1,513,000
Report date
18 Jan 2023
Price
$1.78
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

HERON THERAPEUTICS, INC. /DE/

Security class
Common Stock
Shares / value
177,989
Estimated value
$382,676
Report date
13 Jan 2023
Price
$2.15
Ownership
Direct
Form 4 holding Chief Executive Officer, Director

HERON THERAPEUTICS, INC. /DE/

Security class
Restricted Stock Units
Shares / value
114,807
Estimated value
$246,835
Report date
13 Jan 2023
Price
$2.15
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Barry D. Quart in HERON THERAPEUTICS, INC. /DE/

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .